Captor Therapeutics Spolka Akcyjna
WSE:CTX.WA
105 (PLN) • At close December 14, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) PLN.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 15.825 | 13.201 | 9.158 | 3.986 | 0 | 0 | 0.016 | 0.474 |
| Cost of Revenue
| 9.402 | 6.3 | 2.087 | 0.741 | 6.602 | 4.458 | 2.586 | 0.095 |
| Gross Profit
| 6.423 | 6.901 | 7.071 | 3.245 | -6.602 | -4.458 | -2.57 | 0.379 |
| Gross Profit Ratio
| 0.406 | 0.523 | 0.772 | 0.814 | 0 | 0 | -160.625 | 0.8 |
| Reseach & Development Expenses
| 34.663 | 64.846 | 44.155 | 23.115 | 23.57 | 19.216 | 10.65 | 2.497 |
| General & Administrative Expenses
| 0 | 16.137 | 19.558 | 19.545 | 4.202 | 2.442 | 1.104 | 0.279 |
| Selling & Marketing Expenses
| 0 | 6.039 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 16.52 | 22.176 | 19.558 | 19.545 | 4.202 | 2.442 | 1.104 | 0.279 |
| Other Expenses
| 0 | -7.105 | -18.278 | -7.707 | -15.556 | -13.803 | -7.608 | -2.264 |
| Operating Expenses
| 51.183 | 79.917 | 45.435 | 34.953 | 12.216 | 7.855 | 4.146 | 0.512 |
| Operating Income
| -44.76 | -73.016 | -38.364 | -31.708 | -12.216 | -7.855 | -4.13 | -0.133 |
| Operating Income Ratio
| -2.828 | -5.531 | -4.189 | -7.955 | 0 | 0 | -258.125 | -0.281 |
| Total Other Income Expenses Net
| 6.334 | 2.489 | 2.47 | -0.863 | -0.478 | -0.451 | -0.292 | -0.047 |
| Income Before Tax
| -38.426 | -70.527 | -35.894 | -32.572 | -12.694 | -8.306 | -4.422 | -0.18 |
| Income Before Tax Ratio
| -2.428 | -5.343 | -3.919 | -8.172 | 0 | 0 | -276.375 | -0.38 |
| Income Tax Expense
| 0 | 0.057 | -2.47 | 0.4 | 0.393 | 0.43 | -0.026 | -0.001 |
| Net Income
| -38.426 | -70.584 | -33.424 | -32.972 | -13.087 | -8.736 | -4.422 | -0.18 |
| Net Income Ratio
| -2.428 | -5.347 | -3.65 | -8.272 | 0 | 0 | -276.375 | -0.38 |
| EPS
| -8.25 | -15.19 | -8.02 | -7.99 | -4.02 | -2.68 | -1.36 | -0.055 |
| EPS Diluted
| -8.25 | -15.19 | -8.02 | -7.99 | -4.02 | -2.68 | -1.36 | -0.055 |
| EBITDA
| -32.93 | -64.764 | -28.221 | -24.41 | -5.614 | -3.418 | -1.57 | 0.466 |
| EBITDA Ratio
| -2.081 | -4.906 | -3.082 | -6.124 | 0 | 0 | -98.125 | 0.983 |